Clinical Trial

Substance P-Induced Migraine Attacks Without Aura

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 5, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Substance P is a neuropeptide implicated in the pathogenesis of headache. This study investigates whether its administration can trigger migraine attacks in individuals with migraine without aura.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-05-05.
Trial Details
NCT Number NCT06959004
Lead Sponsor Danish Headache Center
Conditions Migraine
Enrollment 21 participants
Start Date 2025-05-13
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-05